ProLung Names Clark Campbell as Chairman of the Board

Published: Sep 12, 2012

SALT LAKE CITY--(BUSINESS WIRE)--The medical technology company ProLung today announced the naming of current board member Clark A. Campbell, Ph.D. as its new Chairman, replacing William A. Fresh, who continues as a Director. Campbell steps into this role as the company makes preparations to market the ProLung Test, a new tool in the early detection of lung cancer. Studies have shown that the test immediately and accurately identifies malignancy in patients who have been found to have an indeterminate lung mass. This can help solve the crucial problem of late detection, a major factor in lung cancer’s high mortality rate.

Back to news